Teva Pharmaceutical Industries (TEVA) said Tuesday that it has exercised its right to further raise the pool tender cap for its pool 3 notes to a total purchase price of $400 million from $350 million previously.
The pool 3 notes consist of US dollar-denominated 7.875% sustainability-linked senior notes due 2029, Euro-denominated 7.375% sustainability-linked senior notes due 2029, and US dollar-denominated 8.125% sustainability-linked senior notes due 2031, the company added.
Teva said the pool tender caps for the pool 1 notes, which consist of US dollar-denominated 3.150% senior notes due 2026, and the pool 2 notes, which consist of US dollar-denominated 4.750% sustainability-linked senior notes due 2027 and Euro-denominated 3.750% sustainability-linked senior notes due 2027, remain unchanged.
The combined total purchase price of the notes is increased to $2.30 billion from $2.25 billion, Teva said.
A total of $2.60 billion of the pool 1 notes have been tendered, while a total of $1.39 billion of the pool 2 notes and $717.6 million of the pool 3 notes have been tendered so far as part of early tender offer results, Teva said, adding that the tender offers will expire on June 17.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.